About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Austin | 116 Studies

Clinical Trials Ovarian CancerAustin

Ovarian Cancer Clinical Trials in Austin

Find 116 clinical trials for ovarian cancer near Austin, Texas. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Austin

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 116 trials

TerminatedA Phase 1 Study of [225Ac]-FPI-1434 InjectionThis is a first-in-human Phase 1/2, non-randomized, multi-centre, open-label clinical study designed to investigate safety, tolerability, PK, and preliminary anti-tumour activity…NCT03746431·Duarte, California and 12 others RecruitingcfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseThis is an observational case-control study to train and validate a genome-wide methylome enrichment platform to detect multiple cancer types and to differentiate amongst cancer…NCT05366881·Duarte, California and 16 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha ExpressionThis study is designed to evaluate the efficacy and safety of mirvetuximab soravtansine (MIRV) in participants with platinum-resistant high-grade serous epithelial ovarian cancer…NCT04296890·Phoenix, Arizona and 88 others

CompletedFirst-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid TumorsTP-0903 is a novel oral inhibitor that targets AXL kinase and reverses the mesenchymal phenotype associated with advanced cancers.NCT02729298·Phoenix, Arizona and 15 others

CompletedAn Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior ChemotherapyThis is a phase III randomized study comparing induction treatments of Gemcitabine and Carboplatin versus Paclitaxel and Carboplatin, with or without consolidation therapy for…NCT00191646·Phoenix, Arizona and 54 others

RecruitingPhase I Study of SYS6043 in Patients With Advanced/Metastatic Solid TumorsThe goal of this clinical trial is to learn if investigational drug called SYS6043 works in adults with advanced or metastatic solid tumors that have spread or cannot be treated…NCT07424547·Plantation, Florida and 4 others

RecruitingA Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian CancerOvarian cancer is a lethal disease with an estimated 310,000 new cases and 200,000 deaths experienced worldwide in 2020.NCT07059845·La Jolla, California and 85 others

TerminatedEfficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First RelapseThis research is being done to find out if Carboplatin and Taxane works better alone or when given with an experimental drug called MORAb-003(farletuzumab) in subjects with first…NCT00849667·Birmingham, Alabama and 374 others

TerminatedStudy to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian CancerThis is an open-label, single-arm Phase 2 study to evaluate the efficacy and safety of combination of niraparib and dostarlimab (TSR-042) in participants with advanced, relapsed…NCT03955471·Scottsdale, Arizona and 26 others

CompletedEffect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of Tumor Treating Fields (TTFields) concomitant with weekly paclitaxel for…NCT03940196·Phoenix, Arizona and 118 others

TerminatedA Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid TumorsThis is an open-label, dose escalation and dose expansion study of MDK-703 as a monotherapy and in combination with other cancer therapies in adult study participants with…NCT05716295·Sarasota, Florida and 5 others

Not yet recruitingSafety in Ovarian Cancer for Average-Risk Women - AnalysisThis study is designed to evaluate the safety, specificity, and downstream diagnostic burden of the Evident™ Ovarian Cancer Screening Test in average-risk postmenopausal women.NCT07872644·Waltham, Massachusetts and 1 other

RecruitingStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab AdizutecanCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably.NCT05005403·Duarte, California and 47 others

Active not recruitingA Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian CancerOvarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes.NCT03602859·Anchorage, Alaska and 181 others

Active not recruitingA Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsThis is a first-in-human (FIH), multicenter, open-label Phase I study to investigate the safety, tolerability, preliminary antitumor activity, as well as pharmacokinetics (PK) and…NCT05932862·Jacksonville, Florida and 12 others

CompletedPhase I Dose Escalation Study for VIP152 in Patients With Advanced CancerDetermine the safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of VIP152 (BAY 1251152) as monotherapy or in combination in…NCT02635672·Springdale, Arkansas and 15 others

TerminatedClinical Trial for Ovarian Cancer (OvaRex®)This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients.NCT00050375·Huntsville, Alabama and 61 others

CompletedStudy of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsThis is a first-in-human, Phase 1/2 open-label, multicenter, dose-escalation, safety, pharmacokinetics (PK), and biomarker study of CBX-12 in subjects with advanced or metastatic…NCT04902872·New Haven, Connecticut and 3 others

Active not recruitingDose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of escalating doses of RMC-6291 (KRAS G12C(ON) inhibitor) monotherapy in adult…NCT05462717·Springdale, Arkansas and 63 others

CompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerThis is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study of niraparib as maintenance in platinum sensitive ovarian cancer patients who have either…NCT01847274·Phoenix, Arizona and 111 others

PreviousPage 2 of 6Next

Other Conditions in Austin

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia